These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28741512)

  • 1. Re-Evaluating Clonal Dominance in Cancer Evolution.
    Burrell RA; Swanton C
    Trends Cancer; 2016 May; 2(5):263-276. PubMed ID: 28741512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer heterogeneity: converting a limitation into a source of biologic information.
    Rübben A; Araujo A
    J Transl Med; 2017 Sep; 15(1):190. PubMed ID: 28886708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapting clinical paradigms to the challenges of cancer clonal evolution.
    Murugaesu N; Chew SK; Swanton C
    Am J Pathol; 2013 Jun; 182(6):1962-71. PubMed ID: 23708210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumor heterogeneity in epigenetic patterns.
    Assenov Y; Brocks D; Gerhäuser C
    Semin Cancer Biol; 2018 Aug; 51():12-21. PubMed ID: 29366906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour heterogeneity and resistance to cancer therapies.
    Dagogo-Jack I; Shaw AT
    Nat Rev Clin Oncol; 2018 Feb; 15(2):81-94. PubMed ID: 29115304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour heterogeneity and immune-modulation.
    Jamal-Hanjani M; Thanopoulou E; Peggs KS; Quezada SA; Swanton C
    Curr Opin Pharmacol; 2013 Aug; 13(4):497-503. PubMed ID: 23664091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment.
    Apostoli AJ; Ailles L
    Crit Rev Clin Lab Sci; 2016; 53(1):40-51. PubMed ID: 26397062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scale.
    Barber LJ; Davies MN; Gerlinger M
    Curr Opin Genet Dev; 2015 Feb; 30():1-6. PubMed ID: 25555261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic analysis of tumor clonality.
    Teixeira MR; Heim S
    Adv Cancer Res; 2011; 112():127-49. PubMed ID: 21925303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine.
    Hiley C; de Bruin EC; McGranahan N; Swanton C
    Genome Biol; 2014 Aug; 15(8):453. PubMed ID: 25222836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in the Solid Cancer Cell Population and Its Consequences for Cancer Diagnostics and Treatment.
    Brychtová V; Valík V; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):5-13. PubMed ID: 31023018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances for studying clonal evolution in cancer.
    Ding L; Raphael BJ; Chen F; Wendl MC
    Cancer Lett; 2013 Nov; 340(2):212-9. PubMed ID: 23353056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic insights into the morass of metastatic heterogeneity.
    Hunter KW; Amin R; Deasy S; Ha NH; Wakefield L
    Nat Rev Cancer; 2018 Apr; 18(4):211-223. PubMed ID: 29422598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting tumour heterogeneity in flies: genetic basis of interclonal oncogenic cooperation.
    Ohsawa S; Takemoto D; Igaki T
    J Biochem; 2014 Sep; 156(3):129-36. PubMed ID: 25012819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer - An Insurgency of Clones.
    Gisselsson D; Egnell R
    Trends Cancer; 2017 Feb; 3(2):73-75. PubMed ID: 28718446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial designs for evaluating and exploiting cancer evolution.
    Ingles Garces AH; Porta N; Graham TA; Banerji U
    Cancer Treat Rev; 2023 Jul; 118():102583. PubMed ID: 37331179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer evolution: Darwin and beyond.
    Vendramin R; Litchfield K; Swanton C
    EMBO J; 2021 Sep; 40(18):e108389. PubMed ID: 34459009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour heterogeneity: principles and practical consequences.
    Stanta G; Jahn SW; Bonin S; Hoefler G
    Virchows Arch; 2016 Oct; 469(4):371-84. PubMed ID: 27412632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and non-genetic clonal diversity in cancer evolution.
    Black JRM; McGranahan N
    Nat Rev Cancer; 2021 Jun; 21(6):379-392. PubMed ID: 33727690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.